Literature DB >> 9831300

The United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus.

R G Bretzel, K Voigt, H Schatz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831300

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


× No keyword cloud information.
  6 in total

Review 1.  Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Authors:  L J Scott; C M Spencer
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

2.  ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm?

Authors:  Colin G Nichols; Nathaniel W York; Maria S Remedi
Journal:  Diabetes       Date:  2022-03-01       Impact factor: 9.461

3.  Patient perceptions of treatment and illness when prescribed multiple medicines for co-morbid type 2 diabetes.

Authors:  Rebecca J Stack; Chris Bundy; Rachel A Elliott; John P New; J Martin Gibson; Peter R Noyce
Journal:  Diabetes Metab Syndr Obes       Date:  2011-04-11       Impact factor: 3.168

4.  Treatment of mild and moderate type-2 diabetes: open prospective trial with Hintonia latiflora extract.

Authors:  Marta Korecova; Marie Hladikova
Journal:  Eur J Med Res       Date:  2014-03-28       Impact factor: 2.175

5.  Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.

Authors:  Serdar Güler; Surendra Kumar Sharma; Majeed Almustafa; Chong Hwa Kim; Sami Azar; Rucsandra Danciulescu; Marina Shestakova; Duma Khutsoane; Ole Molskov Bech
Journal:  Arch Drug Inf       Date:  2009-06

6.  Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.

Authors:  Maria Sara Remedi; Colin G Nichols
Journal:  PLoS Med       Date:  2008-10-28       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.